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Background: There is limited available data on the subject of patient survival difference between black and non black heart transplant 
recipients. We hypothesized that there is a higher mortality rate among African American (AA) recipients compared to non AA recipients after cardiac 
transplantation.
Methods: We conducted a Human Subjects IRB approved retrospective chart review study at a single center. All AA patients who received heart 
transplant at our center since 1983 were included. Patient characteristics noted include: demographics, pre transplant creatinine and other, device 
implantation, UNOS class at transplant, graft survival, mortality and other complications. Covariates affecting survival in AA and non AA groups were 
studied. 
Results: Among 800 heart recipients, 37 were AA patients. Most common etiology of heart failure in our patients was non ischemic cardiomyopathy 
(89.2%, n= 33) with majority (81.8%, n=27) having idiopathic cardiomyopathy. The average survival among AA is 5.4 years compared to 12 years 
for the non-AA with 1, 5 and 10 year survival rates of 80%, 55%, and 25 %. This was found to be statistically inferior to the survival probabilities 
of 92%, 78%, and 58% for non-AA group (p=0.002). Based on stepwise Cox regression of graft survival, the variables such as ethnicity (p <0.05), 
pre transplant creatinine (p <0.05), presence or absence of device (p <0.005), and UNOS status at transplant (p <0.1) independently predicted 
the outcomes. Kaplan Meier analysis of pre transplant creatinine level and survival showed that AA group did significantly worse for all creatinine 
classes.
Conclusions: Statistically significant difference in outcomes exists between AA and non AA recipients after the cardiac transplantation. AA 
recipients have decreased survival over time after the transplantation. Ethnicity, pre transplant creatinine, UNOS status and presence or absence of 
device at time of transplant are independent predictors of outcome.
